BIP Alliance’s AbbVie ABBV Stock Holding History

BIP Alliance’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-998	Closed	-$209K	–	50
2025 Q1	$209K	Buy	+998	New	+$194K	0.09%	45

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BIP Alliance's ABBV Position: Q2 2025 in Review

BIP Alliance sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 998 shares — an estimated $209K sold.

BIP Alliance first reported a position in ABBV in Q1 2025 and held it in 1 quarter. The position peaked at $209K in Q1 2025. 3,787 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

BIP Alliance reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
BIP Alliance sold 998 AbbVie shares in Q2 2025, an estimated $209K.
BIP Alliance first reported a position in AbbVie in Q1 2025 and held it in 1 quarter.
BIP Alliance's AbbVie position peaked at $209K in Q1 2025.
3,787 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on BIP Alliance's 13F filing for Q2 2025, filed 31 Jul 2025.